• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声心动图提示肺动脉高压:下一步简化处理策略。

Elevated Pulmonary Pressure Noted on Echocardiogram: A Simplified Approach to Next Steps.

机构信息

Cardiovascular Institute Allegheny Health Network Pittsburgh PA.

Department of Medicine Medical University of South Carolina Charleston SC.

出版信息

J Am Heart Assoc. 2021 Apr 6;10(7):e017684. doi: 10.1161/JAHA.120.017684. Epub 2021 Mar 15.

DOI:10.1161/JAHA.120.017684
PMID:33719491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8174323/
Abstract

An elevated right ventricular/pulmonary artery systolic pressure suggestive of pulmonary hypertension (PH) is a common finding noted on echocardiography and is considered a marker for poor clinical outcomes, regardless of the cause. Even mild elevation of pulmonary pressure can be considered a modifiable risk factor, informing the trajectory of patients' clinical outcome. Although guidelines have been published detailing diagnostic and management algorithms, this echocardiographic finding is often underappreciated or not acted upon. Hence, patients with PH are often diagnosed in clinical practice when hemodynamic abnormalities are already moderate or severe. This results in delayed initiation of potentially effective therapies, referral to PH centers, and greater patient morbidity and mortality. This mini-review presents a succinct, simplified case-based approach to the "next steps" in the work-up of PH, once elevated pulmonary pressures have been noted on an echocardiogram. Our goal is for clinicians to develop a good overview of diagnostic approach to PH and recognition of high-risk features that may require early referral.

摘要

超声心动图检查发现右心室/肺动脉收缩压升高提示肺动脉高压(PH),这是一种常见表现,与病因无关,被认为是临床预后不良的标志物。即使肺动脉压轻度升高也被认为是一个可改变的危险因素,影响患者的临床预后轨迹。尽管已经发布了详细的诊断和管理算法指南,但该超声心动图发现往往被低估或未被重视。因此,PH 患者在临床实践中通常在血流动力学异常已经中度或重度时才被诊断。这导致潜在有效治疗的起始延迟、PH 中心的转诊以及患者发病率和死亡率的增加。本篇迷你综述提供了一种简洁、简化的基于病例的方法,介绍了在超声心动图检查发现肺动脉压升高后的 PH 检查的“下一步”。我们的目标是让临床医生对 PH 的诊断方法有一个很好的了解,并认识到可能需要早期转诊的高危特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/8174323/6ef79793945c/JAH3-10-e017684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/8174323/800044f40ff7/JAH3-10-e017684-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/8174323/f04d11e7b7d1/JAH3-10-e017684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/8174323/8483a4a545a8/JAH3-10-e017684-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/8174323/6ef79793945c/JAH3-10-e017684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/8174323/800044f40ff7/JAH3-10-e017684-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/8174323/f04d11e7b7d1/JAH3-10-e017684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/8174323/8483a4a545a8/JAH3-10-e017684-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/8174323/6ef79793945c/JAH3-10-e017684-g001.jpg

相似文献

1
Elevated Pulmonary Pressure Noted on Echocardiogram: A Simplified Approach to Next Steps.超声心动图提示肺动脉高压:下一步简化处理策略。
J Am Heart Assoc. 2021 Apr 6;10(7):e017684. doi: 10.1161/JAHA.120.017684. Epub 2021 Mar 15.
2
Low Pulmonary Artery Pulsatility Index by Echocardiography Is Associated With Increased Mortality in Pulmonary Hypertension.经超声心动图检测的低肺动脉搏动指数与肺动脉高压患者死亡率增加相关。
J Am Soc Echocardiogr. 2023 Feb;36(2):189-195. doi: 10.1016/j.echo.2022.09.003. Epub 2022 Sep 17.
3
Accuracy of echocardiographic estimates of pulmonary artery pressures in pulmonary hypertension: insights from the KARUM hemodynamic database.超声心动图估测肺动脉高压患者肺动脉压力的准确性:来自 KARUM 血流动力学数据库的见解。
Int J Cardiovasc Imaging. 2021 Sep;37(9):2637-2645. doi: 10.1007/s10554-021-02315-y. Epub 2021 Jun 19.
4
Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.心脏磁共振成像、计算机断层扫描和超声心动图在评估结缔组织病患者疑似肺动脉高压中的诊断效用比较。
J Rheumatol. 2012 Jun;39(6):1265-74. doi: 10.3899/jrheum.110987. Epub 2012 May 15.
5
Pulmonary artery systolic pressures estimated by echocardiogram vs cardiac catheterization in patients awaiting lung transplantation.等待肺移植患者中,经超声心动图与心导管检查估计的肺动脉收缩压
J Heart Lung Transplant. 2001 Aug;20(8):833-9. doi: 10.1016/s1053-2498(01)00274-1.
6
Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults.经胸多普勒超声心动图用于检测成人肺动脉高压。
Cochrane Database Syst Rev. 2022 May 9;5(5):CD012809. doi: 10.1002/14651858.CD012809.pub2.
7
The strengths and weaknesses of non-invasive parameters obtained by echocardiography and cardiopulmonary exercise testing in comparison with the hemodynamic assessment by the right heart catheterization in patients with pulmonary hypertension.在肺动脉高压患者中,与通过右心导管进行的血流动力学评估相比,超声心动图和心肺运动试验所获得的无创参数的优缺点。
Adv Med Sci. 2017 Mar;62(1):39-44. doi: 10.1016/j.advms.2016.06.001. Epub 2016 Jun 14.
8
Echocardiographic recognition of pulmonary arterial disease and determination of its cause.超声心动图对肺动脉疾病的识别及其病因的确定。
Am J Med. 1988 Mar;84(3 Pt 1):384-94. doi: 10.1016/0002-9343(88)90257-4.
9
The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension.多普勒超声心动图测定的肺血管容量在肺动脉高压患者中的预后价值。
J Am Soc Echocardiogr. 2006 Aug;19(8):1045-50. doi: 10.1016/j.echo.2006.03.008.
10
Correlation of echocardiographic probability of pulmonary hypertension with maternal outcomes in pregnant women with elevated right ventricular systolic pressure.超声心动图估测肺动脉高压与右心室收缩压升高孕妇母婴结局的相关性。
Echocardiography. 2021 May;38(5):760-766. doi: 10.1111/echo.15050. Epub 2021 Apr 13.

引用本文的文献

1
Right Ventricular-Pulmonary Arterial Coupling in Acute Pulmonary Embolism: Beyond Traditional Prognostic Models.急性肺栓塞中的右心室-肺动脉耦合:超越传统预后模型
Lung. 2025 Jun 29;203(1):72. doi: 10.1007/s00408-025-00831-5.
2
Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies.肺动脉高压:药物及非药物治疗方法
Life (Basel). 2024 Oct 4;14(10):1265. doi: 10.3390/life14101265.
3
MicroRNA-210 mediates hypoxia-induced pulmonary hypertension by targeting mitochondrial bioenergetics and mtROS flux.微小 RNA-210 通过靶向线粒体生物能和 mtROS 流介导低氧诱导的肺动脉高压。

本文引用的文献

1
Evaluation and management of heart failure with preserved ejection fraction.射血分数保留的心力衰竭的评估和管理。
Nat Rev Cardiol. 2020 Sep;17(9):559-573. doi: 10.1038/s41569-020-0363-2. Epub 2020 Mar 30.
2
Association of Mild Echocardiographic Pulmonary Hypertension With Mortality and Right Ventricular Function.轻度超声心动图肺动脉高压与死亡率和右心室功能的关系。
JAMA Cardiol. 2019 Nov 1;4(11):1112-1121. doi: 10.1001/jamacardio.2019.3345.
3
Threshold of Pulmonary Hypertension Associated With Increased Mortality.肺动脉高压相关的死亡率的阈值。
Acta Physiol (Oxf). 2024 Sep;240(9):e14212. doi: 10.1111/apha.14212. Epub 2024 Jul 29.
4
Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER-MRI studies.两项用于识别肺动脉高压(PH)早期检测生物标志物特征的前瞻性多中心研究:CIPHER研究和CIPHER-MRI研究。
Pulm Circ. 2024 Jun 12;14(2):e12386. doi: 10.1002/pul2.12386. eCollection 2024 Apr.
5
Challenges in Echocardiography for the Diagnosis and Prognosis of Non-Ischemic Hypertensive Heart Disease.超声心动图在非缺血性高血压性心脏病诊断和预后评估中的挑战
J Clin Med. 2024 May 4;13(9):2708. doi: 10.3390/jcm13092708.
6
Electrocardiogram Detection of Pulmonary Hypertension Using Deep Learning.深度学习在肺动脉高压心电图检测中的应用。
J Card Fail. 2023 Jul;29(7):1017-1028. doi: 10.1016/j.cardfail.2022.12.016. Epub 2023 Jan 24.
7
Anemia Is an Indicator for Worse Organ Damage Trajectories in Patients with Systemic Sclerosis: A Retrospective Study.贫血是系统性硬化症患者器官损害轨迹恶化的一个指标:一项回顾性研究。
J Clin Med. 2022 Aug 26;11(17):5013. doi: 10.3390/jcm11175013.
8
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide.COPD 相关肺动脉高压的新兴表型:实用指南。
Curr Opin Pulm Med. 2022 Sep 1;28(5):343-351. doi: 10.1097/MCP.0000000000000890. Epub 2022 Jul 16.
9
Surgical Treatment for Empyema Thoracis: Prognostic Role of Preoperative Transthoracic Echocardiography and Serum Calcium.脓胸的外科治疗:术前经胸超声心动图和血清钙的预后作用
J Pers Med. 2022 Jun 20;12(6):1014. doi: 10.3390/jpm12061014.
J Am Coll Cardiol. 2019 Jun 4;73(21):2660-2672. doi: 10.1016/j.jacc.2019.03.482.
4
Heart Failure With Preserved Ejection Fraction In Perspective.射血分数保留的心力衰竭观点述评。
Circ Res. 2019 May 24;124(11):1598-1617. doi: 10.1161/CIRCRESAHA.119.313572.
5
Pulmonary hypertension due to left heart disease.左心疾病所致肺动脉高压。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01897-2018. Print 2019 Jan.
6
Diagnosis of pulmonary hypertension.肺动脉高压的诊断。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01904-2018. Print 2019 Jan.
7
Lack of a Tricuspid Regurgitation Doppler Signal and Pulmonary Hypertension by Invasive Measurement.三尖瓣反流多普勒信号缺失与经侵入性测量的肺动脉高压。
J Am Heart Assoc. 2018 Jun 30;7(13):e009362. doi: 10.1161/JAHA.118.009362.
8
Pulmonary Hypertension: Good Intentions, But a Questionable Approach.肺动脉高压:初衷良好,但方法存疑。
Ann Am Thorac Soc. 2018 Jun;15(6):664-666. doi: 10.1513/AnnalsATS.201803-197ED.
9
Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.肺血管有效动脉弹性作为右心室后负荷的指标及其在左心疾病所致肺动脉高压中的预后价值。
Circ Heart Fail. 2018 Apr;11(4):e004436. doi: 10.1161/CIRCHEARTFAILURE.117.004436.
10
Phosphodiesterase-5 Inhibitor Therapy for Pulmonary Hypertension in the United States. Actual versus Recommended Use.美国的磷酸二酯酶-5 抑制剂治疗肺动脉高压:实际应用与推荐应用。
Ann Am Thorac Soc. 2018 Jun;15(6):693-701. doi: 10.1513/AnnalsATS.201710-762OC.